Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Johnson

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Aminotriazine 5-HT7 antagonistsRonald J Mattson, Derek J Denhart, John D Catt, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2017
Pharmacological and Toxicological Properties of the Potent Oral <i>γ</i>-Secretase Modulator BPN-15606Steven L Wagner, Kevin D Rynearson, Steven K Duddy, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
Journal of Medicinal Chemistry|September 12, 2014
Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt diseaseChristopher L Cioffi, Nicoleta Dobri, Emily E Freeman, et al.
The Journal of Experimental Medicine|March 2, 2021
Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease preventionKevin D Rynearson, Moorthi Ponnusamy, Olga Prikhodko, et al.
Nature Communications|June 8, 2021
A deep learning approach to identify gene targets of a therapeutic for human splicing disordersDadi Gao, Elisabetta Morini, Monica Salani, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
Journal of Medicinal Chemistry|September 23, 2009
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjectsTao Wang, Zhiwei Yin, Zhongxing Zhang, et al.
Structure (London, England : 1993)|June 23, 2015
Outcome of the First wwPDB Hybrid/Integrative Methods Task Force WorkshopAndrej Sali, Helen M Berman, Torsten Schwede, et al.
The Bone & Joint Journal|May 31, 2024
Infographic: Cost-effectiveness analysis of soft bandage and immediate discharge versus rigid immobilization in children with distal radius torus fracturesDaniel C Perry, Melina Dritsaki, Juul Achten, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Aminotriazine 5-HT7 antagonistsRonald J Mattson, Derek J Denhart, John D Catt, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2017
Pharmacological and Toxicological Properties of the Potent Oral <i>γ</i>-Secretase Modulator BPN-15606Steven L Wagner, Kevin D Rynearson, Steven K Duddy, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
Journal of Medicinal Chemistry|September 12, 2014
Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt diseaseChristopher L Cioffi, Nicoleta Dobri, Emily E Freeman, et al.
The Journal of Experimental Medicine|March 2, 2021
Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease preventionKevin D Rynearson, Moorthi Ponnusamy, Olga Prikhodko, et al.
Nature Communications|June 8, 2021
A deep learning approach to identify gene targets of a therapeutic for human splicing disordersDadi Gao, Elisabetta Morini, Monica Salani, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
Journal of Medicinal Chemistry|September 23, 2009
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjectsTao Wang, Zhiwei Yin, Zhongxing Zhang, et al.
Structure (London, England : 1993)|June 23, 2015
Outcome of the First wwPDB Hybrid/Integrative Methods Task Force WorkshopAndrej Sali, Helen M Berman, Torsten Schwede, et al.
The Bone & Joint Journal|May 31, 2024
Infographic: Cost-effectiveness analysis of soft bandage and immediate discharge versus rigid immobilization in children with distal radius torus fracturesDaniel C Perry, Melina Dritsaki, Juul Achten, et al.
Pageof 9